April 2024

Neurovalens closes £2.1m funding round

Neurovalens, a Belfast-headquartered specialist in non-invasive neuro-technology, has closed a £2.1m funding round with existing investors in preparation for a $40m-$50m Series B fundraising round. The firm has also received clearance from the US Food & Drug Administration (FDA) for its Modius Stress device. The below article is taken from: https://www.insidermedia.com/news/ireland/neurovalens-closes-2.1m-funding-round?utm_source=ireland_newsletter&utm_campaign=ireland_news_tracker&utm_medium=deals_article The company, whose medical […]

Neurovalens closes £2.1m funding round Read More »

ABOUT US

Clarendon Fund Managers Limited is a venture capital fund manager based in Belfast, authorised and regulated by the Financial Conduct Authority.

Clarendon Fund Managers Limited is authorised and regulated by the Financial Conduct Authority
The content of the information and materials on the Website and any other information and materials provided by or though CFM in connection with Co-Fund NI and associated investment opportunities and Investee Companies, including any financial promotion as defined in Financial Services and Markets as Act 2000(“FSMA”) constituted thereby, has not been approved by an authorised person within the meaning of FSMA. Reliance on the information provided in relation to any specific Investee Company or otherwise, including any financial promotion constituted thereby, for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested.

April 2024

Neurovalens closes £2.1m funding round

ABOUT US

ADDITIONAL LINKS